Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Perspective on oncogenic processes at the end of the beginning of cancer genomics

Title: Perspective on oncogenic processes at the end of the beginning of cancer genomics
Authors: Ding, L; Bailey, MH; Porta-Pardo, E; Thorsson, V; Colaprico, A; Bertrand, D; Gibbs, DL; Weerasinghe, A; Huang, K-L; Tokheim, C; Cortes-Ciriano, I; Jayasinghe, R; Chen, F; Yu, L; Sun, S; Olsen, C; Kim, J; Taylor, AM; Cherniack, AD; Akbani, R; Suphavilai, C; Nagarajan, N; Stuart, JM; Mills, GB; Wyczalkowski, MA; Vincent, BG; Hutter, CM; Zenklusen, JC; Hoadley, KA; Wendl, MC; Shmulevich, L; Lazar, AJ; Wheeler, DA; Getz, G
Contributors: SAIC-F-Frederick, Inc; Leidos Biomedical Research, Inc.
Source: 320.e10 ; 305
Publisher Information: Elsevier
Publication Year: 2018
Collection: Imperial College London: Spiral
Subject Terms: Science & Technology; Life Sciences & Biomedicine; Biochemistry & Molecular Biology; Cell Biology; SOMATIC POINT MUTATIONS; DISCOVERY; CLASSIFICATION; EXPRESSION; BREAST; TUMORS; LANDSCAPE; DRIVER; IDENTIFICATION; INFORMATION; TCGA; cancer; cancer genomics; omics; oncogenic process; Carcinogenesis; DNA Repair; Databases; Genetic; Genes; Neoplasm; Genomics; Humans; Metabolic Networks and Pathways; Microsatellite Instability; Mutation
Description: The Cancer Genome Atlas (TCGA) has catalyzed systematic characterization of diverse genomic alterations underlying human cancers. At this historic junction marking the completion of genomic characterization of over 11,000 tumors from 33 cancer types, we present our current understanding of the molecular processes governing oncogenesis. We illustrate our insights into cancer through synthesis of the findings of the TCGA PanCancer Atlas project on three facets of oncogenesis: (1) somatic driver mutations, germline pathogenic variants, and their interactions in the tumor; (2) the influence of the tumor genome and epigenome on transcriptome and proteome; and (3) the relationship between tumor and the microenvironment, including implications for drugs targeting driver events and immunotherapies. These results will anchor future characterization of rare and common tumor types, primary and relapsed tumors, and cancers across ancestry groups and will guide the deployment of clinical genomic sequencing.
Document Type: article in journal/newspaper
Language: English
Relation: Cell; http://hdl.handle.net/10044/1/71217; https://doi.org/10.1016/j.cell.2018.03.033; TCGA Pilot Program; 15Y011ST
DOI: 10.1016/j.cell.2018.03.033
Availability: http://hdl.handle.net/10044/1/71217; https://doi.org/10.1016/j.cell.2018.03.033
Rights: © 2018 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Accession Number: edsbas.97F78D8F
Database: BASE